COVID-19：埃及“ Abigan”的临床试验：从4月17日开始，适用于50人
COVID-19：
埃及已开始针对新型冠状病毒进行“阿比甘”临床试验。
埃及当地报纸：今日埃及
17日开始使用新的流感药物“ Abigan”进行临床试验，并宣布已经对50人进行了管理。
患者被接纳到多个机构。
埃及政府：
政府希望通过观察未来的进展来确定“ Abigan”是否对新的冠状病毒有效。
到目前为止，埃及已宣布2844例感染病例和205例死亡。
https://news.tbs.co.jp/sp/newseye/tbs_newseye3958846.html
Egypt to test Japanese anti-viral drug Avigan in clinical trials
CAIRO – 12 April 2020: Egypt is getting ready to conduct clinical trials on samples of the Japanese anti-viral drug Aviral as a treatment for COVID-19,
Advisor to the Minister of Higher Education for International Relations and Agreements for Scientific Research Affairs, Dr. Mohamed Al-Shennawy, said on Sunday.
On Friday, Minister of Higher Education and Scientific Research Khaled Abdel Ghaffar
said the ministry has managed to communicate with the Japanese manufacturer of the antiviral drug Avigan to treat patients with coronavirus (COVID-19).
The drug, developed by a group firm of Fujifilm Holdings Corp., has been stored in Japan as a treatment for influenza.
Reports in China showed that the drug has been effective in treating COVID-19, the respiratory disease caused by the virus.
Fujifilm Holdings Corp said on Thursday it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States, according to the NY Times.
The minister further added that Egypt is joining scientific research with Japan in an attempt to reach a medicine for the novel pandemic.
On March 31, Fujifilm announced the start of a phase III clinical trial of Avigan for COVID-19 patients in Japan.
Egypt Today
https://www.egypttoday.com/Article/1/84595/Egypt-to-test-Japanese-anti-viral-drug-Avigan-in-clinical